Peripheral Arterial Disease
773
87
113
399
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
126 trials with published results (16%)
Research Maturity
399 completed trials (52% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.3%
49 terminated out of 773 trials
89.1%
+2.5% vs benchmark
10%
77 trials in Phase 3/4
32%
126 of 399 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 399 completed trials
Clinical Trials (773)
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System
LineMatrix® Biological Vascular Graft for Infra-renal Arterial Bypass or Replacement
EVERO Drug-coated Balloon (DCB) Randomized Trial
HeartMate App-Based Remote Monitoring for Cardiovascular Risk Factor Management
XPAD European Feasibility Study
Vascular Trial Associated Registry Pilot
Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular Disease
The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease
FORWARD PAD IDE Study With the Shockwave Javelin IVL Catheter
The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study
Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries
Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Use of Thermal Imaging Camera to Assess Perfusion Before and After Vascular Intervention
Adapted Physical Activity in Patients With Lower Limb Peripheral Arterial Disease
Predictors of Major Adverse Limb Events After Endovascular Iliac Stenting: a Real-world Cohort Study
The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate）and Plavix® in Healthy Participants
An All-Comers Observational Study of the MicroStent™ Peripheral Vascular Stent System in Subjects With Peripheral Arterial Disease
VITUS Post-Market Registry